AngioDynamics Company Profile (NASDAQ:ANGO)

About AngioDynamics (NASDAQ:ANGO)

AngioDynamics logoAngioDynamics, Inc. designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company's devices are used in minimally invasive, image-guided procedures. The Company offers products within three product groupings: Peripheral Vascular, Vascular Access and Oncology/Surgery. The Company's Peripheral Vascular products include Fluid Management, Venous, Thrombus Management, as well as other core products. The Company's BioFlo products incorporate Endexo Technology into the manufacturing and design of its Vascular Access products. Its Oncology/Surgery product offerings include its Microwave Ablation products, Radiofrequency Ablation (RFA) and its NanoKnife product lines.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Supplies
  • Sub-Industry: Health Care Equipment
  • Symbol: NASDAQ:ANGO
  • CUSIP: 03475V10
  • Web:
  • Market Cap: $633.33 million
  • Outstanding Shares: 36,715,000
Average Prices:
  • 50 Day Moving Avg: $17.36
  • 200 Day Moving Avg: $16.36
  • 52 Week Range: $14.80 - $18.85
  • Trailing P/E Ratio: 174.24
  • Foreward P/E Ratio: 23.31
  • P/E Growth: 1.80
Sales & Book Value:
  • Annual Revenue: $346.96 million
  • Price / Sales: 1.83
  • Book Value: $13.99 per share
  • Price / Book: 1.23
  • EBITDA: $47.67 million
  • Net Margins: 1.64%
  • Return on Equity: 4.83%
  • Return on Assets: 3.57%
  • Debt-to-Equity Ratio: 0.17%
  • Current Ratio: 2.34%
  • Quick Ratio: 1.48%
  • Average Volume: 248,580 shs.
  • Beta: 1.12
  • Short Ratio: 7.79

Frequently Asked Questions for AngioDynamics (NASDAQ:ANGO)

What is AngioDynamics' stock symbol?

AngioDynamics trades on the NASDAQ under the ticker symbol "ANGO."

How were AngioDynamics' earnings last quarter?

AngioDynamics, Inc. (NASDAQ:ANGO) posted its quarterly earnings data on Thursday, September, 28th. The company reported $0.12 EPS for the quarter, missing the consensus estimate of $0.16 by $0.04. The company earned $85.40 million during the quarter, compared to analysts' expectations of $86.12 million. AngioDynamics had a return on equity of 4.83% and a net margin of 1.64%. The company's revenue for the quarter was down 3.1% on a year-over-year basis. During the same quarter last year, the company earned $0.17 earnings per share. View AngioDynamics' Earnings History.

When will AngioDynamics make its next earnings announcement?

AngioDynamics is scheduled to release their next quarterly earnings announcement on Thursday, January, 4th 2018. View Earnings Estimates for AngioDynamics.

What guidance has AngioDynamics issued on next quarter's earnings?

AngioDynamics issued an update on its FY18 earnings guidance on Thursday, September, 28th. The company provided EPS guidance of $0.64-0.68 for the period, compared to the Thomson Reuters consensus estimate of $0.67. The company issued revenue guidance of $352-359 million, compared to the consensus revenue estimate of $355.58 million.

Where is AngioDynamics' stock going? Where will AngioDynamics' stock price be in 2017?

5 brokerages have issued twelve-month target prices for AngioDynamics' shares. Their forecasts range from $16.00 to $21.00. On average, they expect AngioDynamics' stock price to reach $18.50 in the next twelve months. View Analyst Ratings for AngioDynamics.

What are analysts saying about AngioDynamics stock?

Here are some recent quotes from research analysts about AngioDynamics stock:

  • 1. According to Zacks Investment Research, "AngioDynamics reported a dismal first quarter of fiscal 2018 wherein adjusted earnings and revenues missed the Zacks Consensus Estimate. The company reaffirmed its guidance for fiscal 2018. AngioDynamicis rides on the market’s solid response to Solero, especially within the Microwave Ablation space. Growth in the core Angiographic Catheter business is also likely to fortify the company’s footprint in the global space. On the flipside, AngioDynamics recalled the Acculis Microwave Tissue Ablation System under the Oncology and Surgery segment last quarter. The company also had a high outstanding debt level at the end of the first quarter. Higher debts impose certain operating and financial restrictions which might limit the execution of the company’s core business strategies. AngioDynamics traded below the broader industry in the past year." (10/3/2017)
  • 2. Cantor Fitzgerald analysts commented, "F3Q17 Result Summary. F3Q17 total revenues of $85.6M (down 2.0% y/y), was $3.2M below our estimate of $88.8M and $2.7M below FactSet consensus of $88.3M." (3/30/2017)

Who are some of AngioDynamics' key competitors?

Who are AngioDynamics' key executives?

AngioDynamics' management team includes the folowing people:

  • Howard W. Donnelly, Independent Chairman of the Board
  • James C. Clemmer, President, Chief Executive Officer, Director
  • Michael Greiner, Chief Financial Officer, Executive Vice President
  • Gary Barrett, Senior Vice President,Quality and Regulatory Affairs
  • Ben Davis, Senior Vice President, Business Development
  • Barbara Kucharczyk, Senior Vice President-Global Operations
  • Stephen A. Trowbridge, Senior Vice President, General Counsel
  • Eileen O'Shea Auen, Director
  • Jan Stern Reed, Director
  • David F. Burgstahler, Independent Director

How do I buy AngioDynamics stock?

Shares of AngioDynamics can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is AngioDynamics' stock price today?

One share of AngioDynamics stock can currently be purchased for approximately $17.25.

MarketBeat Community Rating for AngioDynamics (NASDAQ ANGO)
Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  123 (Vote Outperform)
Underperform Votes:  199 (Vote Underperform)
Total Votes:  322
MarketBeat's community ratings are surveys of what our community members think about AngioDynamics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for AngioDynamics (NASDAQ:ANGO) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 3 Hold Ratings, 2 Buy Ratings
Consensus Rating:Hold (Score: 2.40)
Consensus Price Target: $18.50 (7.25% upside)
Consensus Price Target History for AngioDynamics (NASDAQ:ANGO)
Price Target History for AngioDynamics (NASDAQ:ANGO)
Analysts' Ratings History for AngioDynamics (NASDAQ:ANGO)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/8/2017Canaccord GenuityReiterated RatingHold$17.00N/AView Rating Details
9/29/2017KeyCorpReiterated RatingHoldHighView Rating Details
7/19/2017Barclays PLCLower Price TargetEqual Weight$17.00 -> $16.00LowView Rating Details
7/4/2017Cantor FitzgeraldBoost Price TargetOverweight$20.00 -> $21.00LowView Rating Details
4/1/2017Craig HallumSet Price TargetBuy$20.00LowView Rating Details
4/8/2016Piper Jaffray CompaniesInitiated CoverageNeutral$12.00N/AView Rating Details
11/10/2015Raymond James Financial, Inc.DowngradeOutperform -> Market PerformN/AView Rating Details
(Data available from 10/16/2015 forward)


Earnings History for AngioDynamics (NASDAQ:ANGO)
Earnings by Quarter for AngioDynamics (NASDAQ:ANGO)
Earnings History by Quarter for AngioDynamics (NASDAQ ANGO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
1/4/2018$0.16N/AView Earnings Details
9/28/2017Q1 2018$0.16$0.12$86.12 million$85.40 millionViewN/AView Earnings Details
7/18/2017Q4 2017$0.16$0.19$90.72 million$86.90 millionViewN/AView Earnings Details
3/30/2017Q3 2017$0.15$0.19$88.29 million$85.60 millionViewN/AView Earnings Details
1/6/2017Q217$0.16$0.19$91.09 million$89.00 millionViewListenView Earnings Details
10/5/2016Q117$0.13$0.17$86.09 million$88.10 millionViewN/AView Earnings Details
7/13/2016Q416$0.16$0.19$88.64 million$93.40 millionViewListenView Earnings Details
4/7/2016Q3$0.14$0.15$85.43 million$87.40 millionViewListenView Earnings Details
1/7/2016Q216$0.14$0.14$88.67 million$89.20 millionViewN/AView Earnings Details
10/8/2015Q116$0.11$0.11$84.70 million$83.70 millionViewN/AView Earnings Details
7/16/2015Q415$0.14$0.14$91.67 million$90.90 millionViewListenView Earnings Details
4/9/2015Q315$0.15$0.12$88.69 million$86.60 millionViewN/AView Earnings Details
1/8/2015Q215$0.15$0.17$90.90 million$92.10 millionViewN/AView Earnings Details
10/9/2014Q115$0.11$0.16$85.35 million$87.30 millionViewListenView Earnings Details
7/23/2014Q414$0.12$0.18$93.65 million$94.07 millionViewListenView Earnings Details
4/9/2014Q314$0.09$0.16$86.85 million$88.20 millionViewListenView Earnings Details
1/9/2014Q2$0.07$0.14$87.54 million$88.60 millionViewListenView Earnings Details
10/10/2013Q114$0.03$0.04$82.54 million$83.60 millionViewN/AView Earnings Details
7/11/2013Q4 2013$0.06$0.07$86.43 million$90.00 millionViewN/AView Earnings Details
4/8/2013Q3 2013$0.05$0.08$81.70 million$81.60 millionViewN/AView Earnings Details
1/3/2013Q2 2013$0.09$0.10$87.40 million$87.00 millionViewN/AView Earnings Details
10/8/2012Q113$0.09$0.10$84.35 million$83.40 millionViewN/AView Earnings Details
7/12/2012$0.08$0.09ViewN/AView Earnings Details
4/4/2012$0.07$0.09ViewN/AView Earnings Details
1/5/2012$0.12$0.13ViewN/AView Earnings Details
10/6/2011$0.09$0.08ViewN/AView Earnings Details
7/14/2011$0.10$0.11ViewN/AView Earnings Details
4/5/2011$0.12$0.15ViewN/AView Earnings Details
1/4/2011$0.12$0.13ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for AngioDynamics (NASDAQ:ANGO)
2017 EPS Consensus Estimate: $0.61
2018 EPS Consensus Estimate: $0.71
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$0.13$0.13$0.13
Q2 20171$0.17$0.17$0.17
Q3 20172$0.15$0.16$0.16
Q4 20172$0.14$0.16$0.15
Q1 20182$0.14$0.18$0.16
Q2 20182$0.15$0.16$0.16
Q3 20182$0.18$0.23$0.21
Q4 20182$0.15$0.23$0.19
(Data provided by Zacks Investment Research)


Dividend History for AngioDynamics (NASDAQ:ANGO)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for AngioDynamics (NASDAQ:ANGO)
Insider Ownership Percentage: 1.80%
Institutional Ownership Percentage: 95.42%
Insider Trades by Quarter for AngioDynamics (NASDAQ:ANGO)
Institutional Ownership by Quarter for AngioDynamics (NASDAQ:ANGO)
Insider Trades by Quarter for AngioDynamics (NASDAQ:ANGO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/24/2017Jan Stern ReedDirectorBuy316$16.00$5,056.00View SEC Filing  
7/21/2017James C ClemmerCEOBuy5,000$15.79$78,950.00View SEC Filing  
7/20/2017James C ClemmerCEOBuy20,000$15.64$312,800.00View SEC Filing  
4/12/2017Avista Capital Partners Gp, LlMajor ShareholderSell2,350,000$16.00$37,600,000.00View SEC Filing  
8/5/2016Avista Capital Partners Gp, LlMajor ShareholderSell2,241,000$14.62$32,763,420.00View SEC Filing  
8/5/2016David F BurgstahlerDirectorSell2,250,000$14.62$32,895,000.00View SEC Filing  
5/6/2016Charles R GreinerVPSell3,508$12.31$43,183.48View SEC Filing  
4/25/2016Stephen A TrowbridgeSVPSell12,940$12.30$159,162.00View SEC Filing  
4/14/2014Matthew KapustaSVPBuy1,000$13.90$13,900.00View SEC Filing  
10/18/2013Vincent BucciDirectorBuy5,000$15.20$76,000.00View SEC Filing  
10/17/2013Howard W DonnellyDirectorSell20,000$15.06$301,200.00View SEC Filing  
7/22/2013Kevin J GouldDirectorBuy2,700$12.00$32,400.00View SEC Filing  
5/9/2013Charles R GreinerVPSell1,495$10.38$15,518.10View SEC Filing  
3/12/2013Vincent BucciDirectorBuy85,000$10.77$915,450.00View SEC Filing  
2/14/2013Vincent BucciDirectorBuy2,000$12.17$24,340.00View SEC Filing  
1/11/2013Kevin J GouldDirectorBuy2,700$11.58$31,266.00View SEC Filing  
11/5/2012Jeffrey GoldDirectorBuy1,000$10.56$10,560.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for AngioDynamics (NASDAQ:ANGO)
Latest Headlines for AngioDynamics (NASDAQ:ANGO)
DateHeadline logo Analysts Anticipate AngioDynamics, Inc. (ANGO) to Announce $0.17 Earnings Per Share - October 16 at 6:24 AM logoAngioDynamics, Inc. (ANGO) Earns "Hold" Rating from Canaccord Genuity - October 9 at 3:16 PM logoEarnings Review and Free Research Report: Lakeland’s Revenue Jumped 7.4%; EPS Surged 25% - October 4 at 2:21 PM logoAngioDynamicis' (ANGO) Solero MTA System to Drive Growth - October 4 at 2:21 PM logoETFs with exposure to AngioDynamics, Inc. : October 4, 2017 - October 4 at 2:21 PM logoAngioDynamics, Inc. :ANGO-US: Earnings Analysis: Q1, 2018 By the Numbers : October 3, 2017 - October 3 at 3:39 PM logoAngioDynamics, Inc. – Value Analysis (NASDAQ:ANGO) : October 2, 2017 - October 2 at 3:46 PM logoResearch Analysts Set Expectations for AngioDynamics, Inc.'s Q2 2018 Earnings (ANGO) - October 2 at 6:52 AM logoAngioDynamics, Inc. (ANGO) Given Average Rating of "Hold" by Analysts - October 1 at 7:16 PM logoAngioDynamics, Inc. (ANGO) Receives Hold Rating from KeyCorp - September 29 at 11:08 PM logoAngioDynamics, Inc. (ANGO) Posts Earnings Results, Misses Expectations By $0.04 EPS - September 29 at 8:06 AM logoMid-Afternoon Market Update: AngioDynamics Drops On Earnings Miss; Zynerba Pharmaceuticals Shares Spike Higher - September 28 at 9:28 PM logoAngioDynamics misses Street 1Q forecasts - September 28 at 12:51 PM logoAngioDynamics, Inc. (ANGO) Issues FY18 Earnings Guidance - September 28 at 9:06 AM logoAngioDynamics Reports Fiscal 2018 First Quarter Results - September 28 at 6:59 AM logoAngioDynamics misses by $0.04, misses on revenue - September 28 at 6:08 AM logoAngioDynamics, Inc. (ANGO) Scheduled to Post Quarterly Earnings on Tuesday - September 26 at 1:20 AM logoAngioDynamics' BioFlo Platform Strong, Debt Levels High - September 18 at 4:18 PM logoAngioDynamics' BioFlo Platform Strong, Debt Levels High - September 18 at 4:18 PM logoOutcomes in a Nurse-Led Peripherally Inserted Central Catheter Program: A Retrospective Cohort Study Published in CMAJ Open - September 14 at 4:26 PM logoAngioDynamics to Report Fiscal 2018 First Quarter Financial Results - September 14 at 6:23 AM logoAngioDynamics to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference - September 13 at 5:03 PM logoAngioDynamics to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference - September 13 at 5:03 PM logoAngioDynamics, Inc. (ANGO) Given Consensus Recommendation of "Hold" by Brokerages - September 6 at 6:46 PM logoKeyCorp Reaffirms Hold Rating for AngioDynamics, Inc. (ANGO) - August 27 at 1:08 PM logoAngioDynamics, Inc. (ANGO) Expected to Post Quarterly Sales of $86.07 Million - August 23 at 3:24 PM logoETFs with exposure to AngioDynamics, Inc. : August 18, 2017 - August 18 at 9:06 PM logoAngioDynamics (ANGO) Up 10.8% Since Earnings Report: Can It Continue? - August 18 at 4:03 PM logoAngioDynamics (ANGO) Up 10.8% Since Earnings Report: Can It Continue? - August 18 at 4:03 PM logoAngioDynamics, Inc. (ANGO) Given Consensus Rating of "Hold" by Brokerages - August 12 at 6:38 PM logoAngioDynamics (ANGO) Presents At Canaccord Genuity 37th Annual Growth Conference - Slideshow - August 11 at 9:22 PM logoAngioDynamics, Inc. :ANGO-US: Earnings Analysis: Q4, 2017 By the Numbers : August 8, 2017 - August 8 at 3:46 PM logoAngioDynamics to Present at the 2017 Canaccord Genuity Growth Conference - August 7 at 4:46 PM logoAngioDynamics, Inc. (NASDAQ:ANGO) Expected to Announce Quarterly Sales of $86.07 Million - August 4 at 7:08 AM logoIMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of AngioDynamics, Inc. - July 27 at 8:40 PM logoINVESTOR ALERT: Monteverde & Associates PC Announces an Investigation of AngioDynamics, Inc. - ANGO - July 26 at 4:27 PM logoTeleflex (TFX) & AngioDynamics (ANGO) Head-To-Head Analysis - July 25 at 4:24 PM logoFinancial Comparison: AngioDynamics (NASDAQ:ANGO) vs. Teleflex (TFX) - July 25 at 8:30 AM logoINVESTOR ALERT: Goldberg Law PC Announces an Investigation of AngioDynamics, Inc. - July 24 at 11:17 PM logoTeleflex (TFX) and AngioDynamics (ANGO) Head-To-Head Survey - July 24 at 10:18 PM logoJames C. Clemmer Purchases 5,000 Shares of AngioDynamics, Inc. (ANGO) Stock - July 21 at 7:51 PM logoJames C. Clemmer Buys 20,000 Shares of AngioDynamics, Inc. (NASDAQ:ANGO) Stock - July 21 at 7:31 PM logoAngioDynamics, Inc. (ANGO) Forecasted to Post FY2019 Earnings of $0.69 Per Share - July 21 at 4:16 PM logoAngioDynamics, Inc. (NASDAQ:ANGO) to Post Q4 2018 Earnings of $0.21 Per Share, KeyCorp Forecasts - July 21 at 4:16 PM logoCraig Hallum Comments on AngioDynamics, Inc.'s FY2018 Earnings (ANGO) - July 20 at 1:48 PM logoAngioDynamics, Inc. (ANGO) Forecasted to Post Q1 2018 Earnings of $0.14 Per Share - July 20 at 12:42 PM logoAngioDynamics, Inc. breached its 50 day moving average in a Bearish Manner : ANGO-US : July 19, 2017 - July 19 at 5:04 PM logoBarclays PLC Cuts AngioDynamics, Inc. (NASDAQ:ANGO) Price Target to $16.00 - July 19 at 3:05 PM logoEdited Transcript of ANGO earnings conference call or presentation 18-Jul-17 12:00pm GMT - July 19 at 3:27 AM logoAngioDynamics, Inc. (ANGO) - July 18 at 10:25 PM



AngioDynamics (ANGO) Chart for Monday, October, 16, 2017

This page was last updated on 10/16/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.